Tags

Type your tag names separated by a space and hit enter

The economic burden of gout on an employed population.
Curr Med Res Opin. 2006 Jul; 22(7):1381-9.CM

Abstract

OBJECTIVE

To examine the economic burden of illness of gout in an employed population, quantifying the impact on employers annual health benefit costs for medical and prescription claims, sick leave, short- and long-term disability, and workers' compensation.

METHODS

Adjudicated claims data from 300000 employees from 2001 through 2004 were utilized. T-tests were used to compare demographic data and medical costs and services by Agency for Healthcare Research and Quality (AHRQ) diagnostic categories. Two-part models were used to determine average annual health benefit costs overall and medical costs by place of delivery. A risk stratification quintile analysis was also performed utilizing gout-specific medical and pharmaceutical costs.

RESULTS

There were 1171 employees with gout identified (total n = 249 038). All demographic variables between the two groups were statistically different (p <or= 0.05). The total annual cost for the employee with gout versus without gout was $6870 versus $3705, respectively, with significantly higher costs for medical claims, prescription claims, sick leave, short-term disability, and workers' compensation benefits. Costs were significantly higher by location of service for office, outpatient hospital or clinic, inpatient hospital, and laboratory. For the gout cohort, the top major diagnostic category in average cost was 'circulatory system' and in average services was 'endocrine, nutritional, metabolic, and immunologic systems'. Only 0.9% of employees with gout generated 20% of the total gout-specific medical and prescription costs.

CONCLUSION

Gout inflicts a substantial burden of illness upon employers in terms of medical and prescription costs, as well as other work-related benefits.

Authors+Show Affiliations

The JeSTARx Group, Newfoundland, NJ 07435-1710, USA. RBrook@JeSTARx.xomNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

16834837

Citation

Brook, Richard A., et al. "The Economic Burden of Gout On an Employed Population." Current Medical Research and Opinion, vol. 22, no. 7, 2006, pp. 1381-9.
Brook RA, Kleinman NL, Patel PA, et al. The economic burden of gout on an employed population. Curr Med Res Opin. 2006;22(7):1381-9.
Brook, R. A., Kleinman, N. L., Patel, P. A., Melkonian, A. K., Brizee, T. J., Smeeding, J. E., & Joseph-Ridge, N. (2006). The economic burden of gout on an employed population. Current Medical Research and Opinion, 22(7), 1381-9.
Brook RA, et al. The Economic Burden of Gout On an Employed Population. Curr Med Res Opin. 2006;22(7):1381-9. PubMed PMID: 16834837.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The economic burden of gout on an employed population. AU - Brook,Richard A, AU - Kleinman,Nathan L, AU - Patel,Pankaj A, AU - Melkonian,Arthur K, AU - Brizee,Truman J, AU - Smeeding,James E, AU - Joseph-Ridge,Nancy, PY - 2006/7/13/pubmed PY - 2006/8/30/medline PY - 2006/7/13/entrez SP - 1381 EP - 9 JF - Current medical research and opinion JO - Curr Med Res Opin VL - 22 IS - 7 N2 - OBJECTIVE: To examine the economic burden of illness of gout in an employed population, quantifying the impact on employers annual health benefit costs for medical and prescription claims, sick leave, short- and long-term disability, and workers' compensation. METHODS: Adjudicated claims data from 300000 employees from 2001 through 2004 were utilized. T-tests were used to compare demographic data and medical costs and services by Agency for Healthcare Research and Quality (AHRQ) diagnostic categories. Two-part models were used to determine average annual health benefit costs overall and medical costs by place of delivery. A risk stratification quintile analysis was also performed utilizing gout-specific medical and pharmaceutical costs. RESULTS: There were 1171 employees with gout identified (total n = 249 038). All demographic variables between the two groups were statistically different (p <or= 0.05). The total annual cost for the employee with gout versus without gout was $6870 versus $3705, respectively, with significantly higher costs for medical claims, prescription claims, sick leave, short-term disability, and workers' compensation benefits. Costs were significantly higher by location of service for office, outpatient hospital or clinic, inpatient hospital, and laboratory. For the gout cohort, the top major diagnostic category in average cost was 'circulatory system' and in average services was 'endocrine, nutritional, metabolic, and immunologic systems'. Only 0.9% of employees with gout generated 20% of the total gout-specific medical and prescription costs. CONCLUSION: Gout inflicts a substantial burden of illness upon employers in terms of medical and prescription costs, as well as other work-related benefits. SN - 0300-7995 UR - https://www.unboundmedicine.com/medline/citation/16834837/The_economic_burden_of_gout_on_an_employed_population_ L2 - https://www.tandfonline.com/doi/full/10.1185/030079906X112606 DB - PRIME DP - Unbound Medicine ER -